Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd-Rüdiger Balda
Michael Hertl

Showing results (101-110 of 180) with videos related to

Pageof 18
Sort By:
Frontiers in Immunology|December 8, 2018
Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid PatientsRoxana M Chiorean, Adrian Baican, Mayson B Mustafa, et al.
American Journal of Clinical Dermatology|August 20, 2020
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive ReviewRoberto Maglie, Giovanni Genovese, Farzan Solimani, et al.
Clinical Immunology (Orlando, Fla.)|December 18, 2009
Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3Angela Nagel, Angelika Lang, Dorothee Engel, et al.
The British Journal of Dermatology|November 15, 2025
The role of PKC subtype-specific signaling in the regulation of adhesion in human keratinocytes and skin in pemphigusThomas Schmitt, Julia Haneberg, Desalegn Egu, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 17, 2005
[Significant decrease in quality of life in patients with pemphigus vulgaris. Results from the German Bullous Skin Disease (BSD) Study Group]Franziska Mayrshofer, Michael Hertl, Ronald Sinkgraven, et al.
Pediatric Dermatology|January 14, 2016
Childhood Pemphigus Foliaceus with Exclusive Immunoglobulin G Autoantibodies to DesmocollinsShamir Geller, Andrea Gat, Avikam Harel, et al.
Dermatology Research and Practice|July 31, 2010
Targeted immunotherapy with rituximab leads to a transient alteration of the IgG autoantibody profile in pemphigus vulgarisRalf Müller, Nicolas Hunzelmann, Vera Baur, et al.
Orphanet Journal of Rare Diseases|May 31, 2011
Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseasesKinga Csorba, Sabine Schmidt, Florina Florea, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 26, 2014
Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cellsRüdiger Eming, Tina Hennerici, Johan Bäcklund, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 24, 2009
Use of high-dose immunoglobulins in dermatologyAlexander Enk, Gerhard Fierlbeck, Lars French, et al.
Pageof 18

Showing results (101-110 of 180) with videos related to

Sort By:
Pageof 18
Frontiers in Immunology|December 8, 2018
Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid PatientsRoxana M Chiorean, Adrian Baican, Mayson B Mustafa, et al.
American Journal of Clinical Dermatology|August 20, 2020
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive ReviewRoberto Maglie, Giovanni Genovese, Farzan Solimani, et al.
Clinical Immunology (Orlando, Fla.)|December 18, 2009
Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3Angela Nagel, Angelika Lang, Dorothee Engel, et al.
The British Journal of Dermatology|November 15, 2025
The role of PKC subtype-specific signaling in the regulation of adhesion in human keratinocytes and skin in pemphigusThomas Schmitt, Julia Haneberg, Desalegn Egu, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 17, 2005
[Significant decrease in quality of life in patients with pemphigus vulgaris. Results from the German Bullous Skin Disease (BSD) Study Group]Franziska Mayrshofer, Michael Hertl, Ronald Sinkgraven, et al.
Pediatric Dermatology|January 14, 2016
Childhood Pemphigus Foliaceus with Exclusive Immunoglobulin G Autoantibodies to DesmocollinsShamir Geller, Andrea Gat, Avikam Harel, et al.
Dermatology Research and Practice|July 31, 2010
Targeted immunotherapy with rituximab leads to a transient alteration of the IgG autoantibody profile in pemphigus vulgarisRalf Müller, Nicolas Hunzelmann, Vera Baur, et al.
Orphanet Journal of Rare Diseases|May 31, 2011
Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseasesKinga Csorba, Sabine Schmidt, Florina Florea, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 26, 2014
Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cellsRüdiger Eming, Tina Hennerici, Johan Bäcklund, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 24, 2009
Use of high-dose immunoglobulins in dermatologyAlexander Enk, Gerhard Fierlbeck, Lars French, et al.
Pageof 18